KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Return on Assets (2016 - 2024)

Historic Return on Assets for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to 0.02%.

  • Palvella Therapeutics' Return on Assets rose 4900.0% to 0.02% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.02%, marking a year-over-year increase of 4900.0%. This contributed to the annual value of 0.36% for FY2023, which is 7100.0% up from last year.
  • As of Q3 2024, Palvella Therapeutics' Return on Assets stood at 0.02%, which was up 4900.0% from 0.15% recorded in Q2 2024.
  • Palvella Therapeutics' 5-year Return on Assets high stood at 0.14% for Q1 2024, and its period low was 0.57% during Q1 2023.
  • Moreover, its 5-year median value for Return on Assets was 0.33% (2021), whereas its average is 0.29%.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -2500bps in 2021, then skyrocketed by 7100bps in 2024.
  • Quarter analysis of 5 years shows Palvella Therapeutics' Return on Assets stood at 0.3% in 2020, then dropped by -8bps to 0.33% in 2021, then plummeted by -35bps to 0.44% in 2022, then surged by 32bps to 0.3% in 2023, then skyrocketed by 105bps to 0.02% in 2024.
  • Its Return on Assets stands at 0.02% for Q3 2024, versus 0.15% for Q2 2024 and 0.14% for Q1 2024.